CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $835,312 | -21.3% | 18,403 | -2.6% | 0.01% | -16.7% |
Q2 2023 | $1,061,046 | +25.8% | 18,900 | +1.3% | 0.01% | +20.0% |
Q1 2023 | $843,585 | +0.9% | 18,651 | -12.6% | 0.01% | -37.5% |
Q4 2022 | $836,001 | -31.5% | 21,332 | +14.1% | 0.01% | -42.9% |
Q3 2022 | $1,221,000 | -4.3% | 18,689 | -7.7% | 0.01% | 0.0% |
Q2 2022 | $1,276,000 | -6.8% | 20,255 | -5.2% | 0.01% | +16.7% |
Q1 2022 | $1,369,000 | -34.4% | 21,360 | -19.3% | 0.01% | -29.4% |
Q4 2021 | $2,088,000 | -14.5% | 26,479 | +21.4% | 0.02% | -22.7% |
Q3 2021 | $2,442,000 | -13.1% | 21,815 | +16.8% | 0.02% | -8.3% |
Q2 2021 | $2,810,000 | – | 18,671 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |